Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 12Terminated 5Recruiting 4Unknown 3Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 8Gastrointestinal 6Thoracic 3Gynecologic 3Endocrine 3CNS 3Sarcoma 2Other solid neoplasm 2Other hematologic neoplasm 2Head & Neck 2Plasma cell 1Lymphoid 1Genitourinary 1Classical hematology 1

Conditions

Pleural Effusion, Malignant 1Neurotoxicity Syndromes 1Inoperable Stage III Non-small Cell Lung Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Saline Solution × Thoracic × Clear all
NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown
40 enrolled
Thoracic

Pleural Effusion, Malignant

NCT01882621 2016-06-01

Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients

Sun Yat-sen University

Phase 3 Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neurotoxicity Syndromes

NCT01579188 2012-04-19

LucaVax

Kael-GemVax Co., Ltd.

Phase 3 Unknown
600 enrolled
Thoracic

Inoperable Stage III Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡